Ring Aids That Lower The Danger Of HIV Infection Among Women

Since the first HIV infection was found in 1984, the deadly illness has continued to wreak devastation and has grown to be a major burden on numerous countries and healthcare systems.

Despite the fact that the globe has conducted countless studies on the epidemic that has mostly devastated several African countries, there are a few methods of managing the illness that have been used.

The Dapivirine Vaginal Ring is one of the most recent methods of infection control that is still under development and has already been prequalified by the World Health Organization.

The ring aids in lowering the danger of infection among women, particularly those in high-risk circumstances. It is still being evaluated by several nations before receiving permission.

If a woman wants to use it, she should integrate it into her womanhood. The antiviral (ARV) medicine dapivirine is then gradually released into the vaginal tissue to aid in HIV protection at the location of potential infection.

The flexible silicone ring needs to be changed every month because the medicine is released over the course of a month.

Using DVR, a woman can lower her risk of contracting HIV without even asking her male partner’s consent, and the male partner won’t even be aware of it, said Linly Seyama, an officer at John Hopkins College of Medicine.

The drug’s negative effects are minimized in the body because it is only released at the point of contact and barely enters the bloodstream or human tissues.

Keep in mind that the ring only guards against acquiring HIV; it does not shield you from other sexually transmitted infections or unintended pregnancies, which are other problems that women face.

The ring is currently going through the approval procedure in several nations after being prequalified by WHO, which indicates that it satisfies the international requirements for quality, safety, and efficacy.